Humacyte's total assets for Q3 2024 were $114.76M, a decrease of -17.01% from the previous quarter. HUMA total liabilities were $178.49M for the fiscal quarter, a 7.15% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.